Esperion Therapeutics, Inc.
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 12 trials in this atlas.
- Organization
- In this atlas
Overview
Technical summary
Sponsor class industry. No ROR record matches the name exactly.
Trials at a glance
These figures count only the registry trials in this atlas that name Esperion Therapeutics, Inc. as a sponsor: 12 trials, 11 as lead sponsor and 1 as collaborator.
Phase and status
| Phase | Completed | Unknown status | All statuses |
|---|---|---|---|
| Phase 2 | 5 | 0 | 5 |
| Phase 3 | 6 | 0 | 6 |
| Phase 4 | 0 | 1 | 1 |
| All phases | 11 | 1 | 12 |
Start year
| Start year | Trials |
|---|---|
| 2022 | 1 |
| 2018 | 1 |
| 2017 | 2 |
| 2016 | 4 |
| 2014 | 2 |
| 2013 | 1 |
| 2010 | 1 |
Main conditions
Main countries
- United States
- Canada
- Germany
- Netherlands
- Poland
Roles
- Company
- Sponsor
Sector
Industry
The registry's words
Labels as the registry gives them, not rewritten.
- Sponsor name
- Esperion Therapeutics, Inc.
- Sponsor class
- INDUSTRY
Registry records
Assembled by a program from ClinicalTrials.gov. No person wrote or checked these pages, and they are counted apart from the pages that people wrote. Lists of trials come from the registry's own coding and may miss trials.
Registry trials 12
Record details
- Record id
cardio:org-esperion-therapeutics-inc- Content hash
c49635f09e3ebc65b6db4ff3af2433f4defe3636c56202ccefd7499af1fe94af